Organon Reports Results for the First Quarter Ended March 31, 2022
Go back to Organon Reports Results for the First Quarter Ended March 31, 2022| Merck & Co. (NYSE: MRK) | Delayed: 150.33 -2.01 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.34 | 52 Week High | $65.46 | |||
| Open | $150.83 | 52 Week Low | $47.97 | |||
| Day High | $152.22 | P/E | 102.27 | |||
| Day Low | $150.09 | EPS | $1.47 | |||
| Volume | 4,397,470 | |||||
| (NYSE: OGN) | Delayed: 13.78 +0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.77 | 52 Week High | $8.00 | |||
| Open | $13.76 | 52 Week Low | $8.00 | |||
| Day High | $13.78 | P/E | N/A | |||
| Day Low | $13.76 | EPS | $0.00 | |||
| Volume | 4,872,490 | |||||
